Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZSCAN12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | PGBD1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | DNAH14 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | DEF8 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
mRNA | WIPF1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.004 |
mRNA | REV3L | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | NPIPA5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | PTRF | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
mRNA | TEX33 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
mRNA | CXXC1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |